secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2024-09-18T23:59:59+00:00
Accession:  0001193125-24-221406
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 4.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen restates financials for 2023-2024 due to $17.3M revenue timing error; material weakness identified
--------------------------------------------------------------------------------

- Restatement covers Q1'23 through Q2'24; $17.3M payment from cancelled COVID orders was mis-timed.
- Impact: Q1'23 revenue overstated by $17.3M; FY'23 revenue overstated by $6.6M; H1'24 understated by $6.6M.
- Material weakness identified in internal control over revenue recognition; no fraud or misconduct.
- 2024 revenue guidance reaffirmed and updated to $627M-$642M due to timing shift; total revenue unchanged.
- No impact on cash, operations, or strategic outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312524221406/0001193125-24-221406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312524221406/d886256d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-221406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer